Anti-Smoking Messages for Smoking

Not yet recruiting at 1 trial location
LP
Overseen ByLyudmila Popova, Ph.D
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Georgia State University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

\<p\>The goal of this clinical trial is to learn how exposure to anti-smoking social media messages affects quitting-related behaviors. Eligible participants will be adults aged 21 or older who have used menthol cigarettes on at least 4 days during the past 30 days.\</p\> \<br\> \<p\>The main question this study aims to answer is: Does exposure to anti-smoking messages (in the context of a discrete choice experiment \[DCE\] with eye-tracking study) increase quitting-related behaviors over the following 2 weeks?\</p\> \<br\> \<p\>Participants will be randomly assigned to view the messages either immediately or after a 2-week waiting period, allowing researchers to compare quitting-related behaviors between the two groups. The primary outcome is whether participants report making a quit attempt in the 2 weeks following randomization.\</p\> \<br\> \<p\>Participants will:\</p\> \<ul\> \<li\>Complete eligibility screening and baseline questions about demographics and tobacco use.\</li\> \<li\>Be randomly assigned to view the messages immediately or after a 2-week waiting period.\</li\> \<li\>Attend a 1-hour in-person study visit at Georgia State University or the University of California, Santa Barbara.\</li\> \<li\>View 64 anti-smoking social media messages presented in 16 choice sets while their eye movements and pupil dilation are measured using a screen-based eye-tracking device.\</li\> \<li\>Select which messages most attract their attention, which they would be most likely to share, and which would most motivate them to quit smoking.\</li\> \<li\>Complete questions about quitting-related behaviors either during the study visit (waitlist control condition) or through an online questionnaire 2 weeks later (immediate condition).\</li\> \</ul\>

Are You a Good Fit for This Trial?

Inclusion Criteria

I am willing to take part in an in-person study.
Can speak, read, and write in English
I am 21 years old or older.
See 1 more

Exclusion Criteria

Use of multifocal or near-infrared-blocking/heavily tinted corrective lenses such as bifocal, trifocal, or progressive/varifocal lenses, or coatings that impair eye-tracking (single-vision glasses and contact lenses are eligible)
I have an eye condition that affects my ability to focus or see clearly in the center of my vision.

What Are the Treatments Tested in This Trial?

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: DCE exposureExperimental Treatment1 Intervention
Group II: Waitlist ControlActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Georgia State University

Lead Sponsor

Trials
71
Recruited
33,600+

University of California, Santa Barbara

Collaborator

Trials
33
Recruited
3,100+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+